Search

everythinglearnresearchcommunity

for

Search:↓

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Certain immune cells in the skin can stop hair from growing.

Epigenetic changes control how adult stem cells work and can lead to diseases like cancer if they go wrong.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Different lab conditions and light treatment methods change how human skin cells respond to light therapy.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

Epidermal keratinocytes start wound healing and inflammation after schistosome infection.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

MCPIP1 in myeloid cells is important for skin cancer development and healthy hair growth.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

Children with autoimmune gastritis showed improved intestinal health over time and should be checked for other autoimmune conditions.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

The document explains various skin conditions and their treatments.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.